These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 13678383)

  • 1. Angiogenesis of prostate cancer and antiangiogenic therapy.
    Uehara H
    J Med Invest; 2003 Aug; 50(3-4):146-53. PubMed ID: 13678383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-associated angiogenesis: mechanisms, clinical implications, and therapeutic strategies.
    Pluda JM
    Semin Oncol; 1997 Apr; 24(2):203-18. PubMed ID: 9129690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenesis and prostate cancer tumor growth.
    Nicholson B; Theodorescu D
    J Cell Biochem; 2004 Jan; 91(1):125-50. PubMed ID: 14689586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiogenesis as a strategic target for prostate cancer therapy.
    Li Y; Cozzi PJ
    Med Res Rev; 2010 Jan; 30(1):23-66. PubMed ID: 19536866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in understanding angiogenesis through molecular studies.
    Kwon M; Libutti SK
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):26-32. PubMed ID: 16377412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Angiogenesis and antiangiogenic cancer therapy].
    Pour L; Hájek R; Buchler T; Maisnar V; Smolej L
    Vnitr Lek; 2004 Dec; 50(12):930-8. PubMed ID: 15717808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor angiogenesis is associated with MUC1 overexpression and loss of prostate-specific antigen expression in prostate cancer.
    Papadopoulos I; Sivridis E; Giatromanolaki A; Koukourakis MI
    Clin Cancer Res; 2001 Jun; 7(6):1533-8. PubMed ID: 11410487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor angiogenesis.
    Voravud N; Charuruk N
    J Med Assoc Thai; 1999 Apr; 82(4):394-404. PubMed ID: 10410503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgens repress the expression of the angiogenesis inhibitor thrombospondin-1 in normal and neoplastic prostate.
    Colombel M; Filleur S; Fournier P; Merle C; Guglielmi J; Courtin A; Degeorges A; Serre CM; Bouvier R; Clézardin P; Cabon F
    Cancer Res; 2005 Jan; 65(1):300-8. PubMed ID: 15665307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-associated angiogenesis in prostate cancer.
    Fregene TA; Khanuja PS; Noto AC; Gehani SK; Van Egmont EM; Luz DA; Pienta KJ
    Anticancer Res; 1993; 13(6B):2377-81. PubMed ID: 7510938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiogenesis inhibitors in the treatment of prostate cancer.
    Adesunloye BA; Karzai FH; Dahut WL
    Chem Immunol Allergy; 2014; 99():197-215. PubMed ID: 24217611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined antiangiogenic and immune therapy of prostate cancer.
    Huang X; Raskovalova T; Lokshin A; Krasinskas A; Devlin J; Watkins S; Wolf SF; Gorelik E
    Angiogenesis; 2005; 8(1):13-23. PubMed ID: 16132614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endostatin: the logic of antiangiogenic therapy.
    Abdollahi A; Hlatky L; Huber PE
    Drug Resist Updat; 2005; 8(1-2):59-74. PubMed ID: 15939343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor angiogenesis--a potential target in cancer chemoprevention.
    Bhat TA; Singh RP
    Food Chem Toxicol; 2008 Apr; 46(4):1334-45. PubMed ID: 17919802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of androgen suppression and radiation on prostate cancer suggest a role for angiogenesis blockade.
    Woodward WA; Wachsberger P; Burd R; Dicker AP
    Prostate Cancer Prostatic Dis; 2005; 8(2):127-32. PubMed ID: 15643450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current strategies and future directions of antiangiogenic tumor therapy.
    Zhang ZL; Wang JH; Liu XY
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Oct; 35(10):873-80. PubMed ID: 14515202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promotion of angiogenesis by ps20 in the differential reactive stroma prostate cancer xenograft model.
    McAlhany SJ; Ressler SJ; Larsen M; Tuxhorn JA; Yang F; Dang TD; Rowley DR
    Cancer Res; 2003 Sep; 63(18):5859-65. PubMed ID: 14522910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of disease: angiogenesis in urologic malignancies.
    Charlesworth PJ; Harris AL
    Nat Clin Pract Urol; 2006 Mar; 3(3):157-69. PubMed ID: 16528288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adeno-associated virus-mediated antiangiogenic gene therapy with thrombospondin-1 type 1 repeats and endostatin.
    Zhang X; Xu J; Lawler J; Terwilliger E; Parangi S
    Clin Cancer Res; 2007 Jul; 13(13):3968-76. PubMed ID: 17606731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting multiple signaling pathways as a strategy for managing prostate cancer: multifocal signal modulation therapy.
    McCarty MF
    Integr Cancer Ther; 2004 Dec; 3(4):349-80. PubMed ID: 15523106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.